Feds, States Won't Join Allergan Glaucoma Drug FCA Suit
Law360 (October 4, 2019, 3:58 PM EDT) -- The federal government and dozens of states declined to join a whistleblower lawsuit accusing Allergan Inc. of concealing the health risks of its glaucoma medicine and subsequently collecting reimbursements from public insurance programs, according to documents unsealed Friday in Manhattan federal court.
The False Claims Act suit was filed in July 2014 by an anonymous whistleblower who says insurers reimbursed the pharmaceutical powerhouse for Lumigan prescriptions dispensed to patients who weren't warned that it could cause possibly permanent harm to eyelids. The order to unseal the complaint was issued Tuesday.
"The United States and plaintiff states and municipalities would not have...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!